• Zymergen announces $400M in Series C Funding biospectrumasia
    December 18, 2018
    To achieve these results, Zymergen uses artificial intelligence algorithms and robotic genomic “factories” to search the microbial genome, running tens of thousands of experiments to spot subtle signals of improvement
PharmaSources Customer Service